BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Investor
IDEXX Laboratories, Inc. (IDXX) Announces Two-For-One Stock Split And Increase In Share Repurchase Program 5/6/2015
GW Pharmaceuticals plc Announces The Closing Of U.S. Public Offering Of American Depositary Shares (Adss) Raising Approximately $179.2 Million On The NASDAQ Global Market 5/6/2015
Antares Pharma, Inc. (ATRS) Announces Pricing Of Public Offering Of Common Stock 5/6/2015
Paratek Pharmaceuticals, Inc. Announces Closing Of Common Stock Offering 5/6/2015
Two Under-the-Radar Updates Pfizer (PFE) Investors Need to Know About 5/6/2015
Advaxis, Inc. Announces Closing Public Offering Of Common Stock With Gross Proceeds Totaling $53.2 Million 5/6/2015
Galapagos (GLPG.BR) Announces Launch Of Proposed Global Offering 5/6/2015
Galapagos (GLPG.BR) Listed 10 Years On Euronext Amsterdam And Brussels 5/6/2015
Medivir AB (MVRBF)’s Board Of Directors Has Resolved To Repurchase Own Shares 5/6/2015
Thermo Fisher Scientific (TMO) To Host Analyst Meeting 5/6/2015
CEL-SCI (CVM) Announces Proposed Public Offering Of Common Stock 5/6/2015
pSivida (PSDV)'s Drug Delivery Technology Business Model Draws Comparison to Regeneron (REGN) Blockbuster Success 5/5/2015
Bio-Techne (TECH) Declares Dividend 5/5/2015
Aldeyra Therapeutics (ALDX) Launches Proposed Follow-On Public Offering Of Common Stock 5/5/2015
Cytori Therapeutics, Inc. (CYTX) Prices Registered Direct Offering Providing For Up To $25 Million In Equity Financing 5/5/2015
Baxter International (BAX) Declares Quarterly Dividend 5/5/2015
Cardio3 Biosciences Announces Results Of Annual Shareholder Assembly 2015 And Confirmation Of Name Change To Celyad 5/5/2015
Inovio Pharmaceuticals (INO) Closes $87.4 Million Underwritten Financing 5/5/2015
Blueprint Medicines (BPMC) Announces Closing of Initial Public Offering 5/5/2015
SV Bank Exec: New Companies Are Booming, As “Frothy” Market Looks to Novel Science 5/5/2015
Five Things to Take Away From Vertex (VRTX)'s Q1 5/4/2015
Stressed GlaxoSmithKline (GSK) May Put $6.1 Billion Payout on Hold As New Chairman Arrives 5/4/2015
Kite Pharma (KITE) CEO Avoids Big Tax Bite By Selling $95 Million in Stock Before IPO 5/4/2015
China Cord Blood Corporation Receives Notice Of A Transaction Regarding Its 7% Senior Convertible Notes Due 2017 Held By KKR 5/4/2015
EcoScience Corporation Significantly Reduces Number Of Outstanding Common Stock 5/4/2015
Burcon Nutrascience Corp. (BU) Announces Completion Of Over-Subscribed Rights Offering 5/4/2015
Tikcro Technologies Files Annual Report On Form 20-F For The Year Ended December 31, 2014 5/4/2015
Generex Biotechnology Corporation (GNBT) Announces Intention To Dividend A Portion Of Anticipated SMFI Securities To Its Stockholders Upon A Reverse Stock Split 5/4/2015
Webcast Alert: Heska Corporation (HSKA)'s Annual Meeting Of Stockholders Webcast 5/4/2015
Affimed Therapeutics AG (AFMD) Announces Proposed Public Offering Of Common Stock 5/4/2015
Macrocure (MCUR) Files Annual Report On Form 20-F For The Year Ended December 31, 2014 5/4/2015
TetraLogic Pharmaceuticals (TLOG) Announces Pricing Of $25 Million Public Offering 5/1/2015
Lion Biotechnologies, Inc. Announces Pricing Of Secondary Offering Of Shares By Selling Stockholders 5/1/2015
TetraLogic Pharmaceuticals (TLOG) Announces Public Offering Of Common Stock 5/1/2015
BioAmber Inc. Announces Public Offering Of Common Stock 5/1/2015
WuXi PharmaTech Co., Ltd. Announces Receipt Of Proposal 5/1/2015
Northwest Biotherapeutics (NWBO) Rakes In $28.5 Million 5/1/2015
Quintiles (Q) Announces Proposed Offering Of $800 Million Of Senior Notes 5/1/2015
Sarepta (SRPT) Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 5/1/2015
NephroGenex (NRX) Announces Proposed Offering Of Common Stock 5/1/2015
Juniper Pharmaceuticals Reschedules Annual General Meeting 4/30/2015
Pfenex (PFNX) Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 4/30/2015
OncoGenex Pharmaceuticals Inc. (OGXI) Announces Share Purchase Agreement With Lincoln Park Capital Fund, LLC 4/30/2015
Lipocine Inc. (LPCN) Prices $30.2 Million Public Offering Of Common Stock 4/30/2015
Lipocine Inc. (LPCN) Announces Closing Of $34.8 Million Common Stock Offering 4/30/2015
Inovio Pharmaceuticals (INO) Announces Public Offering Of Common Stock 4/30/2015
StemCells (STEM) Announces Closing Of $25 Million Public Offering 4/30/2015
Advaxis, Inc. Announces Proposed Public Offering Of Common Stock 4/30/2015
Inovio Pharmaceuticals (INO) Announces Pricing Of Public Offering Of Common Stock 4/30/2015
Paratek Pharmaceuticals, Inc. Announces Pricing Of Public Offering Of 2,860,000 Shares Of Common Stock 4/30/2015
Advaxis, Inc. Prices $53 Million Public Offering Of Common Stock 4/30/2015
DS Healthcare Group Regains Compliance With Nasdaq Listing Requirements 4/30/2015
Neptune Technologies & Bioressources Inc. Provides Business Update 4/30/2015
Invitation - Presentation Of Sobi's First Quarter 2015 4/30/2015
Bristol-Myers Squibb (BMY) Prices €1.15 Billion Of Senior Notes 4/30/2015
WuXi PharmaTech Co., Ltd. Receives $3.2 Billion Privatization Offer 4/30/2015
Helix Biopharma (TSX:HBP) Closes Additional Private Placement Financing 4/30/2015
Teva (TEVA) Sends Letter To Mylan (MYL) Board 4/30/2015
Sinovac Biotech Ltd. (SVA) Files 2014 Annual Report On Form 20-F 4/29/2015
GW Pharma (GWPH) Raises $179.2 Million NASDAQ Cash 4/29/2015
Oncolytics Biotech Inc. (ONC.TO) Announces Extension To Regain Compliance With Nasdaq's Minimum Bid Price Rule 4/29/2015
Novogen Limited (NVGN) Completes The Private Placement Of Equity 4/29/2015
NeuroDerm Ltd. (NDRM) Files Annual Report On Form 20-F For The Year Ended December 31, 2014 4/29/2015
ProQR Therapeutics B.V. (PRQR) Announces Annual Shareholder Meeting 4/29/2015
Sobi's Board Of Directors Postpones Annual General Meeting Of Shareholders 4/29/2015
Simulations Plus (SLP) Announces Quarterly Cash Dividend Of $0.05 Per Share 4/29/2015
Looking At Biogen (BIIB) Through Warren Buffett's Eyes 4/29/2015
Basilea Pharmaceutica (BSLN.SW) Shareholders Approve All Resolutions Proposed By The Board Of Directors At The Ordinary General Meeting Of Shareholders 4/29/2015
Quintiles (Q) Announces Proposed Refinancing Of Existing Indebtedness 4/29/2015
Golden Meditech Proposes Open Offer To Eligible Shareholders To Subscribe One Offer Share For Every Two Shares Held And To Acquire Outstanding Ordinary Shares Of China Cord Blood Corporation 4/29/2015
GW Pharmaceuticals (GWPH) Announces Proposed Public Offering Of ADSs 4/28/2015
Paratek Pharmaceuticals, Inc. Announces Proposed Public Offering Of Common Stock 4/28/2015
22nd Century Group, Inc. Provides Highlights From Annual Shareholder Meeting 4/28/2015
China Cord Blood Corporation Receives $512 Million Take-Private Offer 4/28/2015
Novogen Limited (NVGN) Regains Full Compliance With NASDAQ Listing Rule 4/28/2015
Syngenta AG (SYT) Annual General Meeting 4/28/2015
ERYtech Pharma Receives The EnterNext Tech 40 Label 4/28/2015
Horizon Pharma (HZNP) Announces Pricing Of Private Offering Of Senior Notes 4/28/2015
Precise Biometrics AB: Resolutions At Precise Biometrics´ Annual General Meeting 2015 4/28/2015
22nd Century Group, Inc. Provides Highlights From Annual Shareholder Meeting 4/28/2015
Bristol-Myers Squibb (BMY) Announces Cash Tender Offer For Up To $400 Million Aggregate Principal Amount Of Its Outstanding Debt Securities 4/28/2015
Buy Vertex (VRTX) Now for $45B Or Risk It All, Analyst Tells Gilead (GILD) 4/27/2015
Pfenex (PFNX) Announces Pricing Of Follow-On Offering 4/27/2015
CytoSorbents, Inc. Issues Letter To Shareholders 4/27/2015
Telesta Therapeutics Provides Key Corporate Updates 4/27/2015
Akorn, Inc. (AKN) To Make Additional Financial Restatements 4/27/2015
INC Research, Inc. (INCR) Files Registration Statement For Secondary Offering 4/27/2015
Coronado Biosciences (CNDO) Changes Its Name To Fortress Biotech 4/27/2015
Sartorius Stedim Biotech Release: New Webinar On Faster cGMP Manufacturing Scale-up Of Biotherapeutics 4/27/2015
Acucela Provides Important Company Updates 4/27/2015
AxoGen, Inc. (AXGN) Announces 2015 Annual Shareholders’ Meeting 4/27/2015
Lipocine Inc. (LPCN) Announces Proposed Public Offering Of Common Stock 4/24/2015
StemCells (STEM) Announces Proposed Public Offering Of Common Stock And Warrants 4/24/2015
Lipocine Inc. (LPCN) Prices $30.2 Million Public Offering Of Common Stock 4/24/2015
Innocoll, Inc. (INNL) Announces Pricing Of Follow-On Offering 4/24/2015
StemCells (STEM) Announces Pricing Of Public Offering To Raise $25 Million 4/24/2015
Athersys (ATHX) To Host Shareholder Conference Call 4/24/2015
Nordic Nanovector – Share Capital Increase Registered 4/24/2015
BioTie Therapies Corp. Release: Notification According To Chapter 9, Section 5 Of The Finnish Securities Markets Act 4/24/2015
SCYNEXIS, Inc. (SCYX) Announces Pricing Of Public Offering Of Common Stock 4/23/2015
Celgene (CELG) To Webcast At Upcoming Investor Conferences And Medical Meetings In May 4/23/2015
Change In BioTie Therapies Corp.' Financial Calendar 2015 4/23/2015
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 4/23/2015
Akebia Therapeutics, Inc. (AKBA) Announces Closing Of Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 4/23/2015
The Nomination Committee’s Proposals To The Annual General Meeting In Karo Bio AB 4/23/2015
Pfizer (PFE) Hosts Annual Meeting Of Shareholders 4/23/2015
Horizon Pharma (HZNP) Announces Closing Of Public Offering Of Ordinary Shares And Full Exercise Of Underwriters' Option To Purchase Additional Shares 4/23/2015
RestorGenex Issues Annual Letter To Stockholders 4/23/2015
Is Immuno-Oncology The Best Area Of Biotech To Invest In Right Now? 4/22/2015
BioMarin (BMRN) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4/22/2015
Tiziana Life Sciences Plc Release: Issue Of Convertible Loan Notes And Warrants 4/22/2015
Annual General Meeting In BioInvent (BOVNF) 4/22/2015
Novogen Limited (NVGN) Conducts Private Placement And Announces Rights Offering To Shareholders 4/22/2015
Ampio Pharmaceuticals, Inc. (AMPE) Announces Investor Call On Thursday, April 23, 4:30 p.m. ET 4/22/2015
SAGE Therapeutics Announces Closing Of $138 Million Public Offering Of Common Stock Including Full Exercise Of Option To Purchase Additional Shares 4/21/2015
Relypsa (RLYP) Announces New Employment Inducement Grants 4/21/2015
Three Bursting Biotech Stocks - One To Buy 4/21/2015
International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 4/21/2015
Baxter International (BAX) To Webcast Annual Meeting Of Shareholders 4/21/2015
Foamix Pharmaceuticals, Ltd. (FOMX) Announces Closing Of Its $69 Million Public Offering Of Ordinary Shares 4/20/2015
Horizon Pharma (HZNP) Announces Proposed Private Offering Of Senior Notes And Intention To Enter Into New Term Loan Facility 4/20/2015
Ipsen (IPN.PA), Active Biotech AB (BTPC) Plummet As Prostate Cancer Drug Flunks Late-Stage Trial 4/17/2015
Admedus Completes Fully Subscribed $16.1 Million Rights Issue 4/17/2015
Horizon Pharma (HZNP) Announces Pricing Of Public Offering Of Ordinary Shares 4/17/2015
Akebia Therapeutics, Inc. (AKBA) Prices Public Offering Of Common Stock 4/17/2015
Pernix (PTX) Announces Pricing Of Private Offering Of $130 Million Of 4.25% Convertible Senior Notes Due 2021 4/17/2015
Epizyme (EPZM) Announces Closing Of Common Stock Offering 4/17/2015
Nuvo Research Inc. (NRI.TO) Updates Company Strategy 4/16/2015
Immune Design Corporation (IMDZ) Prices Public Offering Of Common Stock 4/16/2015
Tokyo Stock Exchange Announces New Rule Affecting Trading Of MediciNova, Inc. Stock In Japan 4/16/2015
Galapagos (GLPG.BR) Files Registration Statement In The United States For A Proposed Global Offering 4/16/2015
Pfizer (PFE) Launches 2014 Integrated Annual Review 4/16/2015
InVivo Therapeutics Corporation (NVIV) Announces Uplisting To Nasdaq 4/16/2015
Pernix (PTX) Provides Business Update 4/16/2015
C. R. Bard, Inc. (BCR) Declares Quarterly Dividend 4/16/2015
Pernix (PTX) Announces Private Offering Of $120 Million Of Convertible Senior Notes Due 2021 4/16/2015
BioAegis Therapeutics Completes Initial $8 Million Convertible Note Round; Round Oversubscribed 4/16/2015
Skystar Bio-Pharmaceutical (CGPN) Announces Receipt Of NASDAQ Non-Compliance Letter Due To Delay In Filing Form 10-K 4/16/2015
Aduro Biotech (ADRO) Launches $119 Million IPO with Hot Cancer Tech 4/16/2015
Foamix Pharmaceuticals, Ltd. (FOMX) Announces Upsizing And Pricing Of Its $60 Million Public Offering Of Ordinary Shares 4/15/2015
Aegerion (AEGR) Grants Stock Options Under Inducement Program 4/15/2015
WuXi PharmaTech Co., Ltd. Files 2014 Annual Report On Form 20-F 4/15/2015
uniQure (QURE) Announces Closing Of Follow-on Public Offering 4/15/2015
Corbus Pharmaceuticals, Inc. Announces Uplisting To The NASDAQ Capital Market 4/15/2015
Akebia Therapeutics, Inc. (AKBA) Announces Proposed Public Offering Of Common Stock 4/15/2015
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C Represents ImmunoGen (IMGN) In $200 Million Transaction 4/15/2015
Axxess Pharma, Inc. Provides Shareholder Update 4/15/2015
SAGE Therapeutics Announces Pricing Of Public Offering Of Common Stock 4/15/2015
The Medicines Company (MDCO) Stock Trading Halted Today 4/15/2015
Now Infused With Cash, Mysterious H3 Biomedicine About to Get Less Shy About What It Does 4/14/2015
Concordia Healthcare (CXR.TO) Announces Upsizing And Pricing Of Senior Notes Offering 4/14/2015
SAGE Therapeutics Announces Proposed Public Offering Of Common Stock 4/14/2015
Roche (RHHBY) Announces Final Results Of Tender Offer For Foundation Medicine, Inc. (FMI) 4/14/2015
Notice Of Annual General Meeting In Karolinska Development AB 4/14/2015
Siegfried Release: Shareholders’ Meeting Approves All Board Proposals 4/14/2015
Dyax Corp. (DYAX) Closes $230 Million Public Offering Of Common Stock 4/14/2015
Pernix (PTX) Announces Launch Of Consent Solicitation For Its 12% Senior Secured Notes Due 2020 4/14/2015
Horizon Pharma (HZNP) Announces Proposed Public Offering Of Ordinary Shares 4/14/2015
Columbia Laboratories, Inc. (CBRX) Begins Trading As Juniper Pharmaceuticals (JNP) 4/13/2015
PTC Therapeutics (PTCT) Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 4/13/2015
Roaring Juno Therapeutics (JUNO) Ends Quest for New Headquarters and Blueprints Plans to Keep Investors Happy 4/10/2015
Death Possibly Linked to Biogen (BIIB) Tecfidera "No Cause for Alarm," Says Analyst 4/10/2015
Mylan (MYL) Offers $30 Billion Bid for Irish Perrigo Company (PRGO), As Share Price Skyrockets 4/10/2015
uniQure (QURE) Announces Pricing Of Follow-On Public Offering 4/10/2015
Cellular Biomedicine Group (CBMG) Upgraded To NASDAQ Global Market 4/10/2015
Galena Biopharma  (GALE) Announces Closing Of Over-Allotment Option, Increasing Total Gross Proceeds To $43.7 Million 4/10/2015
Cerulean Pharma Inc. (CERU) Closes Public Offering Of Common Stock 4/10/2015
Oxis Biotech Inc. Announces Resumption Of Trading Of Common Stock On Euronext Paris 4/10/2015
Antibe Therapeutics Inc. (ATE.V) Completes Final Closing Of Non-Brokered Private Placement Bringing Total Proceeds To $1,250,000 4/10/2015
As AbbVie (ABBV) Eyes Alzheimer's Franchise, Speculation Mounts About a $4.5B Marriage to Acadia (ACAD) 4/9/2015
Conatus Pharma Announces Completion Of Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 4/9/2015
Ceres, Inc. Announces One-For-Eight Reverse Stock Split 4/9/2015
Rhinomed (ASX:RNO) Shareholder Update 4/9/2015
Resolutions Of The Annual Shareholders’ Meeting Of Sartorius AG 4/9/2015
Resolutions Of The Annual Shareholders’ Meeting Of Sartorius AG 4/9/2015
Opexa Therapeutics (OPXA) Announces Completion Of Rights Offering 4/9/2015
Inovio Pharmaceuticals (INO)’ HPV Immunotherapy Recognized As "Best Therapeutic Vaccine" By World Vaccine Congress 4/9/2015
Egalet Announces Closing Of $60 Million Offering of Convertible Senior Notes Due 2020 4/8/2015
Replicel Life Sciences Receives TSX Venture Exchange Approval To Extend Warrant Expiry Dates 4/8/2015
Lexicon Pharmaceuticals, Inc. (LXRX) To Ring The Nasdaq Stock Market Closing Bell 4/8/2015
Trillium Therapeutics Inc. Announces Completion Of Public Offering Of Securities 4/8/2015
Prothena (PRTA) Announces Pricing Of Public Offering Of 3,300,000 Ordinary Shares 4/8/2015
Cellular Biomedicine Group (CBMG) Responds To False Statements And Allegations Made By Short Seller 4/8/2015
uniQure (QURE) Announces Launch Of Follow-On Public Offering 4/8/2015
Raptor Pharmaceutical Inc. (RPTP) Announces Closing Of Underwritten Public Offering And Exercise In Full of Underwriters' Option To Purchase Additional Shares 4/8/2015
InVivo Therapeutics Corporation (NVIV) Announces Implementation Of Reverse Stock Split In Preparation For Planned Uplisting To NASDAQ 4/8/2015
Lonza Group Ltd. (LZAGY.PK) Announces Results Of Annual General Meeting Annual General Meeting Accepts All Motions Proposed By Board Of Directors 4/8/2015
Dyax Corp. (DYAX) Announces Pricing Of $200 Million Public Offering Of Common Stock 4/8/2015
“Batten Down the Hatches” But Look For Opportunity in Rough First Quarter, Says Analyst 4/8/2015
Gilead (GILD) and Amgen (AMGN) Hand Out Dividends; Other Biotechs Feel the Heat So Who's Next? 4/7/2015
CeraPedics, Inc. Announces Closing Of Loan And Equity Financing 4/7/2015
Intercept Pharmaceuticals (ICPT) Announces Completion Of Public Offering 4/7/2015
Prothena (PRTA) Announces Proposed Offering of Ordinary Shares 4/7/2015
Concordia Healthcare (CXR.TO) Announces Proposed Private Offering Of US$610 Million Senior Notes Due 2023 4/7/2015
Cerulean Pharma Inc. (CERU) Announces Pricing Of Public Offering Of Common Stock 4/7/2015
Dyax Corp. (DYAX) Announces Proposed Public Offering Of 7,000,000 Shares Of Common Stock 4/7/2015
CEO Open Letter To Shareholders Of Hasco Medical, Inc. (HASC) 4/7/2015
GeoVax Labs Inc. (GOVX.OB) Issues Letter To Shareholders 4/7/2015
Teva (TEVA)'s Recent Moves Suggest Restructuring Will Focus on Hypertension, Respiratory & CNS Markets 4/6/2015
Analyst: A Complete List of All Major Biosimilars Could Be the A to Z Guide 4/6/2015